US-guided percutaneous radiofrequency ablation of secondary hyperparathyroidism as a bridge to renal transplantation

References

• Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet (London, England). 2020;395(10225):709–733.
   PubMed Web of Science ®Google Scholar
• Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725–1730. doi: 10.1056/NEJM199912023412303.
   PubMed Web of Science ®Google Scholar
• Golingan H, Samuels SK, Camacho P, et al. Management of hyperparathyroidism in kidney transplantation candidates: a need for consensus. Endocr Pract. 2020;26(3):299–304. doi: 10.4158/EP-2019-0392.
   PubMed Web of Science ®Google Scholar
• Seikrit C, Mühlfeld A, Groene HJ, et al. Renal allograft failure in a hyperparathyroid patient following initiation of a calcimimetic. Nat Rev Nephrol. 2011;7(4):237–241. doi: 10.1038/nrneph.2010.169.
   PubMed Web of Science ®Google Scholar
• Lou I, Foley D, Odorico SK, et al. How well does renal transplantation cure hyperparathyroidism? Ann Surg. 2015;262(4):653–659. doi: 10.1097/SLA.0000000000001431.
   PubMed Web of Science ®Google Scholar
• Block GA, Bushinsky DA, Cheng S, et al. Effect of etelcalcetide vs cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: a randomized clinical trial. Jama. 2017;317(2):156–164. doi: 10.1001/jama.2016.19468.
   PubMed Web of Science ®Google Scholar
• Khairallah P, Nickolas TL. Bone and mineral disease in kidney transplant recipients. Clin J Am Soc Nephrol. 2022;17(1):121–130. doi: 10.2215/CJN.03410321.
   PubMed Web of Science ®Google Scholar
• Pihlstrøm H, Dahle DO, Mjøen G, et al. Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Transplantation. 2015;99(2):351–359. doi: 10.1097/TP.0000000000000583.
   PubMed Web of Science ®Google Scholar
• Bleskestad IH, Bergrem H, Leivestad T, et al. Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function. Clin Transplant. 2014;28(4):479–486. doi: 10.1111/ctr.12341.
   PubMed Web of Science ®Google Scholar
• Chadban SJ, Ahn C, Axelrod DA, et al. KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation. Transplantation. 2020;104(4S1):S11–s103. doi: 10.1097/TP.0000000000003136.
   PubMedGoogle Scholar
• Callender GG, Malinowski J, Javid M, et al. Parathyroidectomy prior to kidney transplant decreases graft failure. Surgery. 2017;161(1):44–50. doi: 10.1016/j.surg.2016.10.003.
   PubMed Web of Science ®Google Scholar
• Cianciolo G, Tondolo F, Barbuto S, et al. A roadmap to parathyroidectomy for kidney transplant candidates. Clin Kidney J. 2022;15(8):1459–1474. doi: 10.1093/ckj/sfac050.
   PubMed Web of Science ®Google Scholar
• KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7(1):1–59.
   PubMed Web of Science ®Google Scholar
• Gasparri G, Camandona M, Abbona GC, et al. Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Surg. 2001;233(1):65–69. doi: 10.1097/00000658-200101000-00011.
   PubMed Web of Science ®Google Scholar
• Chen HH, Lin CJ, Wu CJ, et al. Chemical ablation of recurrent and persistent secondary hyperparathyroidism after subtotal parathyroidectomy. Ann Surg. 2011;253(4):786–790. doi: 10.1097/SLA.0b013e318211ccc2.
   PubMed Web of Science ®Google Scholar
• Solbiati L, Giangrande A, De Pra L, et al. Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism. Radiology. 1985;155(3):607–610. doi: 10.1148/radiology.155.3.3889999.
   PubMed Web of Science ®Google Scholar
• Zhuo L, Peng LL, Zhang YM, et al. US-guided microwave ablation of hyperplastic parathyroid glands: safety and efficacy in patients with end-stage renal disease-a pilot study. Radiology. 2017;282(2):576–584. doi: 10.1148/radiol.2016151875.
   PubMed Web of Science ®Google Scholar
• Kovatcheva RD, Vlahov JD, Stoinov JI, et al. High-intensity focussed ultrasound (HIFU) treatment in uraemic secondary hyperparathyroidism. Nephrol Dial Transplant. 2012;27(1):76–80. doi: 10.1093/ndt/gfr590.
   PubMed Web of Science ®Google Scholar
• Peng C, Zhang Z, Liu J, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease. Head Neck. 2017;39(3):564–571. doi: 10.1002/hed.24657.
   PubMed Web of Science ®Google Scholar
• Zeng Z, Peng CZ, Liu JB, et al. Efficacy of ultrasound-guided radiofrequency ablation of parathyroid hyperplasia: single session vs. two-session for effect on hypocalcemia. Sci Rep. 2020;10(1):6206. doi: 10.1038/s41598-020-63299-8.
   PubMed Web of Science ®Google Scholar
• Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089–2100. doi: 10.1111/j.1523-1755.2005.00365.x.
   PubMed Web of Science ®Google Scholar
• Fukagawa M, Yokoyama K, Koiwa F, et al. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial. 2013;17(3):247–288. doi: 10.1111/1744-9987.12058.
   PubMed Web of Science ®Google Scholar
• Morris PJ. Transplantation–a medical miracle of the 20th century. N Engl J Med. 2004;351(26):2678–2680. doi: 10.1056/NEJMp048256.
   PubMed Web of Science ®Google Scholar
• Mathur A, Sutton W, Ahn JB, et al. Association between treatment of secondary hyperparathyroidism and posttransplant outcomes. Transplantation. 2021;105(12):e366–e74. doi: 10.1097/TP.0000000000003653.
   PubMed Web of Science ®Google Scholar
• Schwarz A, Merkel S, Leitolf H, et al. The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism. Transplantation. 2011;91(5):560–565. doi: 10.1097/TP.0b013e3182079431.
   PubMed Web of Science ®Google Scholar
• Evenepoel P, Sprangers B, Lerut E, et al. Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study. Clin Transplant. 2012;26(3):393–402. doi: 10.1111/j.1399-0012.2011.01524.x.
   PubMed Web of Science ®Google Scholar
• Oruc A, Ersoy A, Yildiz A, et al. Effect of parathyroidectomy timing in kidney transplant recipients on graft function. Exp Clin Transplant. 2021;19(4):316–323. doi: 10.6002/ect.2018.0221.
   PubMed Web of Science ®Google Scholar
• Okada M, Hiramitsu T, Ichimori T, et al. Comparison of pre- and post-transplant parathyroidectomy in renal transplant recipients and the impact of parathyroidectomy timing on calcium metabolism and renal allograft function: a retrospective single-center analysis. World J Surg. 2020;44(2):498–507. doi: 10.1007/s00268-019-05124-6.
   PubMed Web of Science ®Google Scholar
• Koh EY, van der Plas WY, Dulfer RR, et al. Outcomes of parathyroidectomy versus calcimimetics for secondary hyperparathyroidism and kidney transplantation: a propensity-matched analysis. Langenbecks Arch Surg. 2020;405(6):851–859. doi: 10.1007/s00423-020-01953-5.
   PubMed Web of Science ®Google Scholar
• van der Plas WY, El Moumni M, von Forstner PJ, et al. Timing of parathyroidectomy does not influence renal function after kidney transplantation. World J Surg. 2019;43(8):1972–1980. doi: 10.1007/s00268-019-04952-w.
   PubMed Web of Science ®Google Scholar
• Littbarski SA, Kaltenborn A, Gwiasda J, et al. Timing of parathyroidectomy in kidney transplant candidates with secondary hyperparathryroidism: effect of pretransplant versus early or late post-transplant parathyroidectomy. Surgery. 2018;163(2):373–380. doi: 10.1016/j.surg.2017.10.016.
   PubMed Web of Science ®Google Scholar
• Jeon HJ, Kim YJ, Kwon HY, et al. Impact of parathyroidectomy on allograft outcomes in kidney transplantation. Transpl Int. 2012;25(12):1248–1256. doi: 10.1111/j.1432-2277.2012.01564.x.
   PubMed Web of Science ®Google Scholar
• Chou FF, Hsieh KC, Chen YT, et al. Parathyroidectomy followed by kidney transplantation can improve bone mineral density in patients with secondary hyperparathyroidism. Transplantation. 2008;86(4):554–557. doi: 10.1097/TP.0b013e3181814b00.
   PubMed Web of Science ®Google Scholar
• Messa P, Cafforio C, Alfieri C. Clinical impact of hypercalcemia in kidney transplant. Int J Nephrol. 2011;2011:906832. doi: 10.4061/2011/906832.
   PubMedGoogle Scholar
• Kasai ET, da Silva JW, Mandarim de Lacerda CA, et al. Parathyroid glands: combination of sestamibi-(99m)Tc scintigraphy and ultrasonography for demonstration of hyperplasic parathyroid glands. Rev Esp Med Nucl. 2008;27(1):8–12. doi: 10.1157/13114364.
   PubMed Web of Science ®Google Scholar
• Takeyama H, Tabei I, Ogi S, et al. Usefulness of intraoperative 99m Tc-MIBI-guided detection for recurrent sites in secondary hyperparathyroidism: a case-controlled study. Int J Surg. 2008;6(3):184–188. doi: 10.1016/j.ijsu.2008.02.006.
   PubMedGoogle Scholar